OTC Markets OTCPK - Delayed Quote USD

Bionoid Pharma Inc. (BINP)

0.0800

+0.0020

+(2.56%)

As of April 25 at 4:00:00 PM EDT. Market Open.

Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit

NEW YORK CITY, NEW YORK / ACCESS Newswire / April 11, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its audited financial statements for the fiscal year ended December 31, 2024. The audit ...

ACCESS Newswire 17 days ago

BINP
+2.56%
Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements

NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced it has engaged Aloba, Awomolo & Partners, a PCAOB-registered accounting firm, as its independent external auditor for the fiscal year ...

ACCESS Newswire 19 days ago

BINP
+2.56%
Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity

NEW YORK, NY / ACCESS Newswire / March 19, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) today announced that it has submitted an application to uplist from the OTC Pink to the OTCQB Venture Market. The application process involves a thorough ...

ACCESS Newswire last month

BINP
+2.56%
Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm

NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the successful completion of its financial audits for the fiscal years 2022 and 2023 by Olayinka Oyebola & Co., a PCAOB-registered ...

ACCESS Newswire last month

BINP
+2.56%
Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025

Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to provide a corporate update as it looks ahead to a promising year in 2025. The company remains committed to its strategic growth plan, which centers on acquiring revenue-positive e-commerce ...

ACCESS Newswire 3 months ago

BINP
+2.56%
Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.

Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the generation of over $100,000 in revenue following the signing of a Binding Letter of Intent (LOI) with Your Supplement Supply Store Ltd. This significant milestone underscores ...

ACCESS Newswire 3 months ago

BINP
+2.56%
Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd.

Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is pleased to announce the signing of a Binding Letter of Intent (LOI) with Vitawin Supplements Ltd. to acquire its premier e-commerce platform,PrimeEnduro.com . This acquisition represents a significant ...

ACCESS Newswire 4 months ago

BINP
+2.56%
AI Maverick: The Next Evolution of Sales Automation Unveiled in Exclusive Podcast

Bionoid Pharma (OTC PINK:BINP) unveils AI Maverick's game-changing sales automation in the latest episode of the BizUnLearned Podcast. Discover how this revolutionary platform is set to transform the traditional sales process, one touchpoint at a ...

ACCESS Newswire 4 months ago

BINP
+2.56%
The End of SDRs? AI Maverick Sales Automation, One Touchpoint at a Time

NEW YORK CITY, NY / ACCESSWIRE / November 26, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) - Bionoid Pharma, Inc. ("Bionoid") ("BINP") (OTC Pink:BINP), the new owner of the AI Maverick platform, is disrupting the world of sales and communication ...

ACCESS Newswire 4 months ago

BINP
+2.56%
Bionoid Pharma, Inc. Launches Enhanced Supplements Ltd. to Drive Strategic E-Commerce Expansion

TORONTO, ON / ACCESSWIRE / November 19, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) is excited to announce the incorporation of its wholly owned subsidiary, Enhanced Supplements Ltd., a critical step in advancing the company's strategic transition ...

ACCESS Newswire 5 months ago

BINP
+2.56%
Bionoid Pharma, Inc. Signs Binding Letter of Intent to Acquire Main E-Commerce Platform of Your Supplement Supply Store Ltd.

TORONTO, ON / ACCESSWIRE / November 12, 2024 / Bionoid Pharma, Inc. ("Bionoid") (OTC PINK:BINP) is excited to announce the signing of a Binding Letter of Intent (LOI) with Your Supplement Supply Store Ltd. to acquire its leading e-commerce platform, ...

ACCESS Newswire 5 months ago

BINP
+2.56%
Bionoid Pharma, Inc. Engages Olayinka Oyebola & Co. as PCAOB External Auditor for Annual Financial Audit

TORONTO, ON and NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) is pleased to announce the formal engagement of Olayinka Oyebola & Co., a PCAOB-registered firm, as the company's external auditor. This appointment ...

ACCESS Newswire 5 months ago

BINP
+2.56%
Bionoid Pharma, Inc. Unveils Five-Year Strategic Roadmap

AI-Driven Platform and Strategic Acquisitions to Drive Health & Wellness Growth and Profitability TORONTO, ON / ACCESSWIRE / November 5, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) has outlined a five-year roadmap focused on expanding revenue ...

ACCESS Newswire 5 months ago

BINP
+2.56%
Bionoid Pharma, Inc. Acquires AI Maverick Intel

"Pioneering Fully Automated AI Customer Acquisition" TORONTO, ON / ACCESSWIRE / August 8, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC PINK:BINP) announces the signing of a definitive agreement with Stronghold Media Group Corp. ("Stronghold") to acquire ...

ACCESS Newswire 8 months ago

BINP
+2.56%
Bionoid Pharma Announces Agreement to Acquire AiMaverickIntel.com

TORONTO, ON / ACCESSWIRE / June 18, 2024 / Bionoid Pharma, Inc. ("BINP") (OTC Pink:BINP) today announced that it has entered into a Letter of Intent to acquire AiMaverickIntel.com, a leading Audience Acquisition platform powered by Artificial Intelligence ...

ACCESS Newswire 10 months ago

BINP
+2.56%

Performance Overview

Return	BINP	S&P 500 (^GSPC)
YTD	-74.03%	-6.78%
1-Year	-68.00%	+7.51%
3-Year	-92.00%	+27.88%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Bionoid Pharma Inc. (BINP)

Bionoid Pharma Inc. Announces Completion of 2024 Financial Audit

Bionoid Pharma Inc. Engages Aloba, Awomolo & Partners as External Auditor for 2024 Financial Statements

Bionoid Pharma Announces Filing of OTCQB Application to Enhance Market Visibility and Liquidity

Bionoid Pharma, Inc. Announces Completion of 2022 and 2023 Financial Audits by PCAOB-Registered Firm

Bionoid Pharma, Inc. Provides Corporate Update and Outlines Growth Strategy for 2025

Bionoid Pharma, Inc. Reports Over $100,000 in Revenue Following Binding LOI With Your Supplement Supply Store Ltd.

Bionoid Pharma, Inc. Moves to Expand E-Commerce Presence With Binding Agreement to Acquire Platform From Vitawin Supplements Ltd.

AI Maverick: The Next Evolution of Sales Automation Unveiled in Exclusive Podcast

The End of SDRs? AI Maverick Sales Automation, One Touchpoint at a Time

Bionoid Pharma, Inc. Launches Enhanced Supplements Ltd. to Drive Strategic E-Commerce Expansion

Bionoid Pharma, Inc. Signs Binding Letter of Intent to Acquire Main E-Commerce Platform of Your Supplement Supply Store Ltd.

Bionoid Pharma, Inc. Engages Olayinka Oyebola & Co. as PCAOB External Auditor for Annual Financial Audit

Bionoid Pharma, Inc. Unveils Five-Year Strategic Roadmap

Bionoid Pharma, Inc. Acquires AI Maverick Intel

Bionoid Pharma Announces Agreement to Acquire AiMaverickIntel.com

Performance Overview